(1)
ShresthaS. B.; BhusalM.; JwarchanJ.; GautamS.; ShresthaP. R. Efficacy and Safety of Intralesional Immunotherapy With Tuberculin Purified Protein Derivative Among Cutaneous Wart Patients. J Nepal Health Res Counc 2023, 20, 881-885.